Rituximab administration following autologous stem cell transplantation for multiple myeloma is associated with severe IgM deficiency. (Q51026916)
Jump to navigation
Jump to search
scientific article published in March 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rituximab administration following autologous stem cell transplantation for multiple myeloma is associated with severe IgM deficiency. |
scientific article published in March 2004 |
Statements
Rituximab administration following autologous stem cell transplantation for multiple myeloma is associated with severe IgM deficiency. (English)
1 reference
Seah H Lim
1 reference
Yana Zhang
1 reference
Zhiqing Wang
1 reference
Rupashree Varadarajan
1 reference
Phillip Periman
1 reference
W Vance Esler
1 reference
1 March 2004
1 reference
1 reference
103
1 reference
5
1 reference
1971-1972
1 reference